Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model

被引:266
|
作者
Merlini, Mario [1 ]
Rafalski, Victoria A. [1 ]
Coronado, Pamela E. Rios [1 ]
Gill, T. Michael [1 ]
Ellisman, Maya [1 ]
Muthukumar, Gayathri [1 ]
Subramanian, Keshav S. [1 ]
Ryu, Jae Kyu [1 ]
Syme, Catriona A. [1 ]
Davalos, Dimitrios [1 ,4 ]
Seeley, William W. [2 ]
Mucke, Lennart [1 ,2 ]
Nelson, Robert B. [3 ,5 ]
Akassoglou, Katerina [1 ,2 ]
机构
[1] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
[3] Lundbeck Res USA, Paramus, NJ 07652 USA
[4] Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA
[5] Univ Rhode Isl, Ryan Inst Neurosci, MindImmune Therapeut, Kingston, RI 02881 USA
基金
瑞士国家科学基金会;
关键词
TRANSGENIC MICE; MATTER; ASSOCIATION; MECHANISM; DECLINE; PLAQUES;
D O I
10.1016/j.neuron.2019.01.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebrovascular alterations are a key feature of Alzheimer's disease (AD) pathogenesis. However, whether vascular damage contributes to synaptic dysfunction and how it synergizes with amyloid pathology to cause neuroinflammation and cognitive decline remain poorly understood. Here, we show that the blood protein fibrinogen induces spine elimination and promotes cognitive deficits mediated by CD11b-CD18 microglia activation. 3D molecular labeling in cleared mouse and human AD brains combined with repetitive in vivo two-photon imaging showed focal fibrinogen deposits associated with loss of dendritic spines independent of amyloid plaques. Fibrinogen-induced spine elimination was prevented by inhibiting reactive oxygen species (ROS) generation or genetic ablation of CD11b. Genetic elimination of the fibrinogen binding motif to CD11b reduced neuroinflammation, synaptic deficits, and cognitive decline in the 5XFAD mouse model of AD. Thus, fibrinogen-induced spine elimination and cognitive decline via CD11b link cerebrovascular damage with immune-mediated neurodegeneration and may have important implications in AD and related conditions.
引用
收藏
页码:1099 / +
页数:16
相关论文
共 50 条
  • [41] Protective mechanism of testosterone on cognitive impairment in a rat model of Alzheimer's disease
    Yan, Xu-Sheng
    Yang, Zhan-Jun
    Jia, Jian-Xin
    Song, Wei
    Fang, Xin
    Cai, Zhi-Ping
    Huo, Dong-Sheng
    Wang, He
    [J]. NEURAL REGENERATION RESEARCH, 2019, 14 (04) : 649 - 657
  • [42] Neuromuscular Dysfunction Precedes Cognitive Impairment in a Mouse Model of Alzheimer's Disease
    Brisendine, Matthew H.
    Nichenko, Anna S.
    Bandara, Aloka B.
    Willoughby, Orion S.
    Amiri, Niloufar
    Weingrad, Zach
    Specht, Kalyn S.
    Bond, Jacob M.
    Addington, Adele
    Jones III, Ronald G.
    Murach, Kevin A.
    Poelzing, Steven
    Craige, Siobhan M.
    Grange, Robert W.
    Drake, Joshua C.
    [J]. FUNCTION, 2023, 5 (01):
  • [43] Protective mechanism of testosterone on cognitive impairment in a rat model of Alzheimer's disease
    Xu-Sheng Yan
    Zhan-Jun Yang
    Jian-Xin Jia
    Wei Song
    Xin Fang
    Zhi-Ping Cai
    Dong-Sheng Huo
    He Wang
    [J]. Neural Regeneration Research, 2019, 14 (04) : 649 - 657
  • [44] CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer’s disease
    Wenting Xie
    Dong Guo
    Jieyin Li
    Lei Yue
    Qi Kang
    Guimiao Chen
    Tingwen Zhou
    Han Wang
    Kai Zhuang
    Lige Leng
    Huifang Li
    Zhenyi Chen
    Weiwei Gao
    Jie Zhang
    [J]. Cell Death & Differentiation, 2022, 29 : 2417 - 2428
  • [45] CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer's disease
    Xie, Wenting
    Guo, Dong
    Li, Jieyin
    Yue, Lei
    Kang, Qi
    Chen, Guimiao
    Zhou, Tingwen
    Wang, Han
    Zhuang, Kai
    Leng, Lige
    Li, Huifang
    Chen, Zhenyi
    Gao, Weiwei
    Zhang, Jie
    [J]. CELL DEATH AND DIFFERENTIATION, 2022, 29 (12): : 2417 - 2428
  • [46] Cognitive impairment in patients with Alzheimer's disease and Parkinson's disease
    Chyniak, O.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S289 - S289
  • [47] A Random Change Point Model for Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment
    Yu, Lei
    Boyle, Patricia
    Wilson, Robert S.
    Segawa, Eisuke
    Leurgans, Sue
    De Jager, Philip L.
    Bennett, David A.
    [J]. NEUROEPIDEMIOLOGY, 2012, 39 (02) : 73 - 83
  • [48] Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment
    Lindeboom, J
    Weinstein, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) : 83 - 86
  • [49] HDAC9-mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease
    Zhang, Hai-Long
    Hu, Shufen
    Yang, Pin
    Long, Han-Chun
    Ma, Quan-Hong
    Yin, Dong-Min
    Xu, Guang-Yin
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (02)
  • [50] Mild cognitive impairment: Aging to Alzheimer's disease
    Heilbronner, RL
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (05) : 718 - 722